In particular, the expression levels of SNAI2/Slug and vimentin (VIM), which are crucial regulators of mesenchymal transition in breast cancer, were evaluated after treatment with each inhibitor as well as their combination. The gene discussed is SNAI2; the disease is breast cancer.